A new wave of lawsuits has emerged against pharmaceutical companies producing GLP-1 receptor agonists, including Ozempic, alleging that the drugs…
Read More
Novo Nordisk Faces Setback as Alzheimer’s Trial for Ozempic Fails
COPENHAGEN — Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight‑loss drugs including Ozempic, faced a major…
Read More
